Found: 6
Select item for more details and to access through your institution.
In Vitro Cytotoxicity and Zebrafish Embryos Acute Toxicity Assessment of Ruthenium (II) Metal-based Complexes in Combination with PARP inhibitor.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2024, v. 20, p. 99
- By:
- Publication type:
- Article
In Vitro Cytotoxicity of Ruthenium (II) Polypyridyl Complex in Combination with PARP Inhibitor in A549 Lung Cancer Spheroids Model.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2024, v. 20, p. 98
- By:
- Publication type:
- Article
Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy.
- Published in:
- ChemMedChem, 2020, v. 15, n. 22, p. 2121, doi. 10.1002/cmdc.202000391
- By:
- Publication type:
- Article
PARP Inhibition Enhances the Anticancer Activity of Ruthenium(II) Polypyridyl Complex, [Ru(Dppz)2pip]<sup>2+</sup> in Lung Cancer Cells.
- Published in:
- Current Trends in Biotechnology & Pharmacy, 2020, p. 35
- By:
- Publication type:
- Article
Ruthenium (II) polypyridyl complex, [Ru(dppz)<sub>2</sub>PiP]<sup>2+</sup> synergized with PARP inhibitor for breast cancer treatment.
- Published in:
- Current Trends in Biotechnology & Pharmacy, 2020, p. 30
- By:
- Publication type:
- Article
Synergy of ruthenium metallo-intercalator, [Ru(dppz)<sub>2</sub>(PIP)]<sup>2+</sup>, with PARP inhibitor Olaparib in non-small cell lung cancer cells.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28454-x
- By:
- Publication type:
- Article